Angioplasty overused among millions of patients, evidence shows
Every day, thousands of people enter hospitals for angioplasties—a procedure that will cost about $12,000, take a week of recuperation, and require a year or more of drug therapy. And, in many cases, it's probably unnecessary. Angioplasties have grown into a $10 billion industry in the United States, and there is no dispute that they can be a lifesaver for patients in the throes of a heart attack. But angioplasties aren't risk-free, and evidence is mounting that the procedure is overused among the millions of patients who have the kind of stable heart disease that doesn't foretell a heart attack. New studies indicate that cardiologists often don't evaluate these patients adequately before doing angioplasties, and patients often have inflated ideas about how important an angioplasty is to their survival.
- Healthcare Leaders Seek Strategic Sweet Spot
- 3 Reasons Wellness Programs Fail
- CMS Issues Health Insurance Exchange Proposed Rules
- Patients Shoulder Nearly 25% of Medical Bills
- ACOs Widespread, Yet Challenged
- Healthcare Costs 'An Abomination' Says Senate Finance Committee Chair
- Healthcare Consolidation: M&A Not the Only Way
- MGMA: Physician Compensation Increasingly Based on Quality Measures
- 6 CNO-to-CEO Strategies
- PwC: Pace of Rising Medical Costs Slowing
